SOPHiA GENETICS SA
SOPH
$7.50
-$0.12-1.58%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 23.65% | 20.85% | 18.56% | 13.66% | 7.31% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.65% | 20.85% | 18.56% | 13.66% | 7.31% |
| Cost of Revenue | 28.08% | 23.93% | 18.64% | 14.72% | 9.08% |
| Gross Profit | 21.54% | 19.41% | 18.53% | 13.15% | 6.50% |
| SG&A Expenses | 19.95% | 21.72% | 16.19% | 9.75% | 2.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 178.54% | 165.95% | 162.30% | 80.74% | 75.40% |
| Total Operating Expenses | 16.70% | 17.05% | 12.50% | 8.00% | 2.13% |
| Operating Income | -9.52% | -13.05% | -6.56% | -2.63% | 2.73% |
| Income Before Tax | -12.49% | -23.02% | -26.47% | -2.37% | -8.16% |
| Income Tax Expenses | -71.26% | -10.50% | 23.63% | 310.24% | 156.51% |
| Earnings from Continuing Operations | -10.20% | -22.31% | -26.41% | -5.02% | -9.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.20% | -22.31% | -26.41% | -5.02% | -9.90% |
| EBIT | -9.52% | -13.05% | -6.56% | -2.63% | 2.73% |
| EBITDA | -10.09% | -14.55% | -8.20% | -3.84% | 1.60% |
| EPS Basic | -4.27% | -17.96% | -23.42% | -2.94% | -7.81% |
| Normalized Basic EPS | -6.49% | -18.70% | -23.52% | -0.39% | -6.15% |
| EPS Diluted | -4.27% | -17.96% | -23.42% | -2.94% | -7.81% |
| Normalized Diluted EPS | -6.49% | -18.70% | -23.52% | -0.39% | -6.15% |
| Average Basic Shares Outstanding | 5.74% | 3.84% | 2.46% | 1.81% | 1.79% |
| Average Diluted Shares Outstanding | 5.74% | 3.84% | 2.46% | 1.81% | 1.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |